DOP073 Submucosal injection of the oligonucleotide STNM01 is able to induce clinical remission, mucosal healing and histological response in left-sided ulcerative colitis patients with moderate-to-severe disease
Raja Atreya(Friedrich-Alexander-Universität Erlangen-Nürnberg), Markus F. Neurath(Friedrich-Alexander-Universität Erlangen-Nürnberg), Tanja Kühbacher(University Hospital Schleswig-Holstein), Shuji Terai(Niigata University Medical and Dental Hospital), Toshifumi Hibi∥(Kitasato Institute Hospital), Christian Maaser(Klinikum Lüneburg), Maximilian J. Waldner(Friedrich-Alexander-Universität Erlangen-Nürnberg), Babett Holler(University Hospital Leipzig), Torsten Kucharzik(Klinikum Lüneburg), Junji Yokoyama(Niigata University Medical and Dental Hospital), Simon Hirschmann(Friedrich-Alexander-Universität Erlangen-Nürnberg), R. Abu Hashem(Asklepios), Hidesaku Asakura, Johanna Dinter(Poliklinik für Endokrinologie, Diabetologie und Präventivmedizin), Kenji Suzuki(Niigata University Medical and Dental Hospital), Joachim C. Mertens(GastroZentrum Hirslanden Zürich), Hiroyuki Yoneyama(Io Therapeutics (United States)), Oliver Drvarov(Asklepios), Joachim Mössner, Christoph Schramm(Poliklinik für Endokrinologie, Diabetologie und Präventivmedizin)
Cited by 2
Related Papers
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
|Immunity|2013|4.7k
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
|Journal of Crohn s and Colitis|2018|1.8k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
|Journal of Crohn s and Colitis|2019|1.4k